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The TCR for recognition of antigen is a disulphide-linked heterodimer made
of two membrane glycoproteins, a and (3, which are expressed on the cell
membrane in association with an invariant complex of proteins, T3 (1-3). Recent
studies (4-9) have identified in both the thymus and peripheral blood a subset
of T cells that carry on the cell membrane another type of TCR/T3 complex
that includes the product of the T cell-specific gene y (TCR-y/T3).
Bone marrow T cell progenitor clones may express germline transcripts for
the y but not for the a or the # TCR genes before migrating to the thymus (10) .
Studies carried out with heterogeneous populations of 15-d fetal thymocytes
(FT)' showed that some of these cells have rearranged and express (3 and -t genes
(11, 13). Very little is known about the state of the TCR-a gene during ontogeny
within the thymus. mRNA for the TCR-a gene could be detected in FT at day
17 of gestation (14, 15).
Mouse thymocytes at day 14 of gestation express Thy-1 and Ly-1 but not
L3T4 or Lyt-2 T cell surface antigens (16, 17). The limited number of cells
obtainable from 14-d embryonic thymuses has hampered the study of the
configuration of the TCR-a, -J3, and -y genes in these cells.
FT can be induced to proliferate in vitro either with the combination of PMA,
ionomycin, and the growth factor IL-2 (18) or with PMA plus the cytokine IL-4
(19, 20).
To study the cellular and molecular properties of 14-d FT and to further our
knowledge of the effects of IL-4 on growth and differentiation of T cell
precursors, we attempted to establish in culture FT clones. Here we report the
establishment of 13 independently isolated thymocyte clones from a 14-d mouse
embryo and the molecular, cellular, and functional characterization of eight of
such clones.
The Basel Institute for Immunology was founded and is supported by F. Hoffman-La Roche and
Co., Ltd., Basel, Switzerland. P. Sideras' present address is Dept. of Medical Chemistry, Kyoto
University Faculty of Medicine, Sakyo-Ku, Kyoto 606,Japan. Address correspondence to Dr. Ronald
Palacios, Basel Institute for Immunology, Grenzacherstrasse 487, CH-4058 Basel, Switzerland.
' Abbreviations used in this paper:
￿
FT, fetal thymocytes; GFCM, growth factor-conditioned
medium; IMDM, Iscove's modified Dulbecco's medium.
J. Exp. MED. © The Rockefeller University Press - 0022-1007/87/11/1245/14 $2.00
￿
1245
Volume 166
￿
November 1987
￿
1245-12581246
￿
INTRATHYMIC T CELL PRECURSOR CLONES
Materials and Methods
Reagents.
￿
PMA (Sigma Chemical Co., St. Louis, MO), ionomycin (Calbiochem-Behring
Corp., San Diego, CA), ['H]thymidine (TRA 120; Radiochemical Centre, Amersham,
United Kingdom), Iscove's modified Dulbecco's medium (IMDM Gibco Laboratories,
Grand Island, NY), Con A (Pharmacia Fine Chemicals, Uppsala, Sweden), PHA (Wellcome
Research Laboratories, Darford, United Kingdom), LPS (Sigma Chemical Co.), and FCS
(Ready Systems Laboratories, Basel, Switzerland) were the reagents used.
Mice.
￿
C57BL/6, CBA/J, DBA/2, and B10.BR mice are bred and maintained in our
animal facilities. B10.BR embryos were obtained from timed matings; the day of vaginal
plug was designated day zero.
Separation of Cells.
￿
Thymocyte cell suspensions from fetal B10.BR mice (14 d of
gestation) were prepared as described (21) and were kindly provided to us by Mrs. Katrin
Hafen (Basel Institute for Immunology). The FT cell suspensions were treated with a
mixture of anti-la (M5/114), Mac-1 (M1/70), and antigranulocyte (GM1 .2) mAbs plus
complement (22) to eliminate putative myeloid cells contained in these preparations of
cells. Spleen cell suspensions were prepared as described (23) and T cells were eliminated
from CBA/J spleen cellsby treatment with a mixture ofmonoclonal anti-T cell antibodies
and complement as detailed elsewhere (23). The cell preparations were washed and
resuspended in culture medium (IMDM supplemented with 5% heat-inactivated FCS, 5
x 10-5 M 2-ME, and 50 Ag/ml of gentamycin) at the desired concentrations.
Monoclonal Antibodies.
￿
mAbs against the following surface antigens were used: Ly-1
(53-7-313), Lyt-2 (53-63-72, 3168 .81), L3T4 (GK1 .5, RL-172), Thy-1 .2 (30 H12),J1 ld.l,
Mac-1 (MI/70), Pgp-1 (142/5), B-220 (14 .8), IL-2-R (7134, PC61), Ia (M5/114.15.2,
10.2.16), H-213° (15-5-5S), LFA-1 (FD441-8). The reports describing the characteristics
of all these mAbs are listed elsewhere (10, 18, 19, 22). The hamster anti-mouse T3 mAb
145-2CM (24) was a gift of Dr. J. Bluestone (National Institutes of Health, Bethesda,
MD). FITC-conjugated goat anti-rat Ig (Nordic Immunological Laboratories, Tilburg,
The Netherlands), FITC-labeled goat anti-mouse Ig (Southern Biotechnology Associates,
Inc., Birmingham, AL), FITC-labeled goat anti-hamster Ig (Nordic Immunological Lab-
oratories) and FITC-conjugated sheep anti-mouse Ig that crossreacts with rat Ig (a kind
gift of Luciana Forni, Basel Institute for Immunology) were used as second-step reagents
in immunofluorescence staining procedures.
Cytokines.
￿
Human rIL-2 (25), human rIL-1 (Cistrom Technologies, Pine Brook, NJ).
Mouse rIL-4 (19, 26) produced by transfected HeLa H-109 cells was purified by gel
filtration chromatography. The purified recombinant material has identical biochemical
characteristics and biological activities to those of IL-4 purified from Th clones (26, 27,
and Sideras, P., unpublished results). Supernatants from Con A-stimulated 2.19 Th line
were obtained as described (27); they contain IL-3, IL-5, and IL-4 (80 U/ml, assessed in
the IgGl-inducing factor assay [27]), and no detectable IL-2 or IFN--y activities (27 and
our unpublished results).
Establishment in Culture of Fetal Thymocyte Clones.
￿
Single 14-d FT from a B10.BR
mouse were placed by micromanipulation in round-bottomed microplates containing
growth factor-conditioned medium (GFCM, culture medium supplemented with 5%
supernatant from Con A-stimulated 2.19 Th line) and PMA (10 ng/ml). GFCM without
PMA was used subsequently unless indicated otherwise. 3 d later, 100 ul of fresh GFCM
were added to each well, and thereafter, every 3 d 100 /i1 of the medium was replaced
with 100 Al of fresh GFCM. After 15-20 d of culture, we observed that 13 of 172 wells
contained confluent cell layers. Each of the 13 confluent cultures was transferred into
macroculture plates (Linbro Chemical Co., Hamden, CT) and cultured in a final volume
of 0.5 ml of GFCM per Linbro well. As the cultures reached confluency, they were
subcultured in two to three new Linbro wells in a final volume of 0.5-1 .0 ml of GFCM
per well. Once each of the 13 FT clones were expanded up to 24 Linbro wells per clone,
they were harvested, washed once, and then further expanded in 50-ml tissue culture
plastic flasks at 2-3 x 105 cells/ml GFCM. Samples of each FT clone were frozen by
standard procedures (22) at this time. The FT clones could be transferred to new flasks
with continued growth every 2-3 d and were therefore considered established clonesPELKONEN ET AL.
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(September 1986). Eight FT clones were chosen at random for further study and the
remaining five FT clones were frozen. The FT clones D11, H5, D5, H12, G12, E10, F1,
and A2 have been maintained in culture with GFCM at the conditions indicated above.
Other Cell Lines. The LD1 Th line (23), the EL-4 T lymphoma, and the T hybrid
HK301 (obtained by fusing 15-d FT with BW5147 T lymphoma cells) (Pelkonen, J.,
unpublished results) were maintained in culture medium. The 2 .19 Th line (27) was
maintained and expanded in culture medium supplemented with IL-2-containing super-
natants and stimulation with x-ray irradiated C57BL/6 spleen cellsas described (27). The
4E7 T killer line that recognizes minor histocompatibility antigens in the context of H-2'`
was derived from BALB/c spleen cells stimulated with BALB.K-irradiated spleen cells as
described (28).
Isolation and Analysis ofNucleic Acids.
￿
DNA and RNA preparation, restriction enzyme
digestions, agarose gel electrophoresis, DNA blotting procedures, probe preparations,
hybridization procedures, and autoradiography were performed as described (29, 30).
y Gene Complex Probe.
￿
The Cy l cDNA probe (900-bp Ava I-Eco RI cDNA clone
containing all the C-y1 coding region and its 3' untranslated region) (14), the Jy 1 probe
(1 .2-kb Ava I-Hind III genomic fragment) (30), and the Cy2 probe (1 .0-kb Eco RI-Hind
III genomic fragment (30) were used.
Gene Complex Probe.
￿
The 4.1 cDNA probe specific for the constant region of the S
gene complex (11), the pj#1 probe (Bam HI-Eco RI genomic fragment) (31, 32), and the
pjf2 probe (Cla I-Eco RI genomic fragment) (31, 32) were used.
a Gene ComplexProbe.
￿
The a chain probe used is the 300-bp Nco I-Ava 11 fragment
from the constant portion of the a chain cDNA cloneT1 .2 (33).
RNA-RNA In Situ Hybridization.
￿
The FT clones and the LD1 T cell line stimulated
with PMA (10 ng/ml) and ionomycin (500 ng/ml) at 37°C for 2-4 h or unstimulated
were assayed for the presence of mRNA for IL-4 by RNA-RNA in situ hybridization as
described below and elsewhere (20).
Cytocentrifuge Preparations.
￿
Glass slides were immersed in 70% ethanol and air dried.
The cells suspended in balanced salt solution containing 10% FCS were loaded on glass
slides (105 cells/slide) with the aid of a cytocentrifuge. The cell smears were fixed in
paraformaldehyde (4% diluted in PBS) for 1 min, were transferred into a solution of 70%
ethanol, and were subsequently stored at +4°C until used.
Preparation of the IL-4 Probe.
￿
The Rsa I-Rsa I fragment from the cDNA clone
pSP6KmIL4-293 (26) containingall the coding sequence for IL-4 was subcloned into the
gemini, SP6/T7 vectors. The pUC18 vector containing the Rsa I-Rsa I fragment was
kindly provided by Dr. T. Honjo (Kyoto University, Kyoto, Japan). Linearized plasmids
were used as templates for the synthesis in vitro ofradioactive RNA probes complementary
to the cellular IL-4 mRNA. RNA was also transcribed from the opposite direction (sense)
and used as a negative control. -2 X 108 cpm were incorporated into RNA per microgram
of RNA template. The size of the full-length probe mRNA was -400 nucleotides.
In Situ Hybridization.
￿
Fixed slides prepared as described above were rinsed twice in
2X SSC (20X SSC = 3 M NaCl, 0.3 M sodium citrate) and then acetylated (pH 8, 0.25%
acetic anhydride) for 10 min. After this, the slides were rinsed in 2X SSC and PBS, then
immersed in 0.1 M Tris-HCl, 0.1 M glycine, pH 7.0, for 30 min before hybridization.
20 jl of probe mixture (10 Al formamide-20% dextran sulfate, 2 Al sheared herring-
sperm DNA [10 mg/ml], 2 Al nuclease-free BSA [20 mg/ml], 1 j,1 labeled RNA [106
cpm/kl]) were loaded on each slide and hybridization was performed at 50°C for 3 h.
The slides were washed three times with 50% formamide, 2X SSC at 52 °C, rinsed in 2X
SSC, and treated with 30 Al RNase solution for 30 min at 37°C (100 kg/ml RNase A plus
1 ug/ml RNase-T1). The slides were rinsed twice in 2X SSC, once in 50% formamide, 2X
SSC at 52°C, rinsed again three times in 2X SSC, were dehydrated in 70, 80, and 90%
ethanol, respectively, were air dried, and finally were autoradiographed. Kodak nuclear
track emulsion (NTB-2, Eastman Kodak Co., Rochester, NY) was melted at 43 ° C and
diluted with an equal volume of water. The slides were dipped into the emulsion and
allowed to solidify horizontally at room temperature for 3-4 h. The emulsion-coated
slides were kept at +4 °C for 3-5 d for exposure. The slides were developed in Kodak1248
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developer-19 at +15 ° C for 5 min. After a rinse in tap water the fixation was carried out
in Kodak fixer for 5 min and the slides were washed with water for 30 min. The slides
were stained with 10% Giemsa stain for 2.5 min, washed twice with tap water, and were
air dried. We considered as positive cells (cells expressing IL-4-mRNA) those cells that
had >10 grains per cell. Elsewhere (20) we have shown that (a) cold IL-4-RNA synthesized
in the sense orientation inhibits the binding ofthe radioactive probe to the cellular mRNA,
and (b) no hybridization is observed either when the cytocentrifuge preparations are
pretreated with RNase or when RNA probes synthesized in the wrong orientation are
used (20), demonstrating the validity and specificity of the technique for the detection of
IL-4-mRNA.
Immunofuorescence Staining and Flow Cytometry Analysis (FACS).
￿
This procedure was
carried out as described in detail before (10, 22) using FITC-conjugated anti-mouse Ig,
anti-rat Ig, and anti-hamster Ig as second-step reagents. Dead cells were excluded from
analysis by using propidium iodide. The fluorescence emitted by single viable cells was
measured using logarithmic amplification and the data collected from 10' cells were
analyzed with a program in a Consort 30 computer and histograms were generated.
Proliferative Responses to Cytokines.
￿
The cells were harvested in logphase of growth,
washed three times, and resuspended in culture medium. The cells (10) were incubated
in microculture wells in a final volume of 200 Al of culture medium containing the
following agents: rIL-1 (5-50 U/ml), rIL-2 (10-500 U/ml), rIL-4 (final dilutions, 1 :4 to
1 :256), PMA (10 ng/ml), or the combination of PMA + rIL-2 (100 U/ml). The cultures
in triplicate were incubated at 37°C for 24 and 48 h. Cell growth was measured by both
direct visualization of the cultures with an inverted microscope and ['Hlthymidine uptake
(37 KBq/well) during the last 5-6 h of the culture period. The data are expressed as
counts per minute and are the mean of triplicate samples.
Helper and Cytotoxic T Cell Functions.
￿
The capacity of the FT clones to assist T cell-
depleted spleen B cells from CBA/J mice to generate antibody-secreting cells was studied
in a Con A-facilitated microculture assay as detailed before (23). The number of antibody-
secreting cells was determined by the reverse hemolytic protein A plaque assay after 5 d
of culture at 37°C. The results are expressed as PFC per culture and are the mean of
duplicate cultures.
The capacity of the FT clones to exert cytolytic activity was tested in a PHA-facilitated
microcytotoxicity assay using as target cells "Cr-labeled LPS-stimulated spleen cells from
CBA/J and DBA/2 mice or EL-4 T lymphoma cells and were performed as described
(28). The results are expressed as percent of specific "Cr release.
Results
Establishment in Culture ofFTClones
Single FT from 14-d embryonic thymus of B10.BR mice were placed in
microculture wells by micromanipulation and the cultures were supplemented
with GFCM. 13 independently isolated clones were established out of 172
cultures as detailed in experimental procedures. Eight clones, called FT D11,
FT H5, FT D5, FT G12, FT H12, FT E10, FT F1, and FT A2, were chosen at
random for further study and the other five clones were frozen . The FT clones
were established in September 1986 and maintained in culture up to present by
culturing them in fresh GFCM every 2 d.
Configuration and Expression ofthe TCR--y, -#, and -a Genes
The eight FT clones chosen for further study were expanded and analyzed
for the expression of the TCR-y, -f, and -a genes and surface phenotype.
The expression of mRNA for TCR-y, -fl, and -a genes in the FT clones was
studied by Northern blot analysis. The results show that all FT clones havePELKONEN ET AL.
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mRNA for the y gene and that none of them contain detectable mRNA for the
TCR-# or -a genes (Fig. 1).
Next, we assessed the configuration of the TCR genes in the FT clones by
Southern blot analysis. The state of the y l , y3, and y4 gene clusters (the
nomenclature for the y gene clusters is that proposed by Traunecker et al .
[311) was assessed using the PJy 1 probe and Hind III-digested DNAs from liver
and the FT clones. This analysis shows that all eight clones contain the 71 and
the y4 genes in germline configuration (Fig. 2C) and that the B10 .BR mouse
strain like other mice (DBA/2, B10.A, CBA/J) do not have the y3 pseudogene
(Fig. 2C). No evidence for rearrangement of the y2 gene cluster was found
using the Cy2-specific probe and Eco RI-digested DNAs (not shown).
Using probes specific for the Jal and the J,B2 regions, respectively, and Eco
RI-digested DNAs we found that all eight FT clones contain both the al (Fig.
2A) and the (32 (Fig. 2B) genes in germline configuration.
Due to the long distance spanning the Ja chromosomal region, the presence
of rearrangements of the TCR-a gene is more difficult to determine. We are in
the process of generating genomic probes that will cover the ^-60-kb Ja chro-
mosomal region to be able to detect TCR-a gene rearrangements.
Surface Phenotype
The phenotype of the FT clones was determined by immunofluorescence
staining and FACS using a panel of mAbs against cells of the T cell, B cell, and
myeloid cell lineages . Three distinct phenotypes were found.
Phenotype I.
￿
The FT clones E10, Fl, D5, and H5 express Thy-1, Ly-1, Lyt-
2, Pgp-1, and IL-2-R but no detectable L3T4 or T3 surface molecules (Fig. 3).
Phenotype IL. The FT clones A2 and G12 resemble the FT clones with
phenotype I except that they do not express detectable IL-2-R as assessed with
the two anti-IL-2-R mAbs 7D4 (Fig. 3) and PC61 (not shown).
Phenotype III.
￿
The FT D 11 and FT H 12 clones differ from the FT clones
with phenotypes I and II in that they express L3T4 (Fig. 3).
None of the eight FT clones have detectable IgM, la, B-220, or Mac-1
molecules on the cell membrane, and all of them are H-2k+ and LFA-1 +.
Growth Requirements
The next set of experiments was designed to define the growth factors used
by the FT clones to continuously proliferate in vitro. All eight FT clones grow
in rIL-4 but not in rIL-1 . All six IL-2-R+ FT clones also proliferate in rIL-2,
albeit to a lesser extent than in IL-4 (Table I). The FT clones A2 and G12 do
not express receptors for IL-2 (Fig. 3). However, both FT A2 and FT G12
clones can be induced to express IL-2-R (assessed by FACS analysis with 7D4
and PC61 mAbs) by treating them with PMA (not shown), and the PMA-treated
A2 and G12 FT clones proliferate in rIL-2 (Table I). PMA by itself is not
mitogenic on the FT clones.
The PC61 and 7D4 anti-IL-2-R antibodies strongly inhibited the action of rIL-
2 on the FT clones but did not significantly affect the action of rIL-4 (Fig. 4)
indicating that IL-4 promotes growth of the FT clones via an IL-2-independent
pathway. These results show that the FT clones can use both IL-4 and IL-2 as1250
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1A
IL2R
Thy1
)5~~
Pgp-1
LOG FLUORESCENCE INTENSITY
T3
Lyt
￿
LyT2
TABLE I
Growth Factorsfor the FT Clones
FIGURE 3. Phenotypic char-
acterization of the FT clones.
The presence of the various
cell surface antigens indicated
above on the FT clones was
determined by direct or in-
direct immunofluorescence
staining and FACS analysis.
The surface characteristics of
theFT clones fall into the fol-
lowing three phenotypes: I, il-
lustrated by the FT clone H5;
II, exemplified by the FT
clone G12;andIII, illustrated
by the data obtained with the
FT clone D11 .
* The FT clones indicated above were cultured in medium containing AL-1 (20 U/ml), rIL-2 (100
U/ml), rIL-4 (final dilution 1:16), PMA (10 ng/ml) or PMA + rIL-2, at 37°C for 24 h. Cell
proliferation wasassessed by ['H]thymidine uptake during thelast 5 hof the culture period.
t TheFT clones A2 and G12, unlike the otherFT clones, do notexpress IL-2-R. PMA induces both
A2 and G12 cells to express IL-2-R as determined by FACS analysis using 7D4 or PC61 mAbs
specific for IL-2-R.
Responding
FT clone*
Cell
Medium
proliferation
rIL-4
driven by
rIL-2
(['H]thymidine uptake,
rIL-2 +
PMA
cpm X 10-'):
PMA rIL-1
A2$ 381 7,656 772 8,210 305 482
D5 280 16,532 8,404 - - 305
F1 214 12,287 5,842 - - 586
D11 299 10,248 4,671 - - 350
H5 286 12,080 6,848 - - 278
G12t 272 10,332 968 7,120 311 304
H12 328 20,241 10,123 - - 510
E10 201 13,775 5,065 - - 322PELKONEN ET AL .
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FIGURE 4 . Anti-IL-2-R mAbs
inhibit the proliferative response
of the FT clones to AL-2 but not
to rIL-4 . Both 7D4 and PC61
anti-IL-2-R mAbs were added
to cultures (final concentration
10%) containinf, cells of the FT
clones (5 X 10 /well) and either
AL-2 (50 U/ml) or AL-4 (final
dilution, 1 :16) . Cell proliferation
was measured by ['H]thymidine
uptake. The results are expressed
as cpm X 10' (mean t SE of
triplicate samples). The results
are illustrated with the data ob-
tained with the FT clones F1 and
D11.
growth factors in vitro. The FT clones self-renew in vitro in rIL-4 every 10-14
h and die within 48-72 h in the absence ofexogenous growth factors.
Functions
The FT clones were tested for three T cell functions : help to B lymphocytes,
cytolytic activity, and synthesis of IL-4 .
We studied whether the FT clones synthesize IL-4 . This was of particular
interest in light of our previous work (20) showing that 1 of 10 FT at day 14 of
gestation synthesizemRNA for IL-4 after stimulation withPMA plus ionomycin,
as assessed by RNA-RNA in situ hybridization . Thus the FT clones stimulated
withPMA + ionomycin at 37'C for 2-4 h or unstimulated were assayed for the
presence ofmRNA for IL-4 by RNA-RNA in situ hybridization . The LD1 T
cell line was included in these experiments and served as a negative control . We
found that all eight FT clones synthesized IL-4-mRNA after stimulation byPMA
+ ionomycin . No IL-4-mRNA was detected in the unstimulated FT clones or in
the stimulated LD 1 T cells (negative control) . No hybridization to the cellular
RNA from stimulated FT clones was observed using radiolabeled probe synthe-
sized in the wrong orientation (notshown) . Theamount ofIL-4-mRNAproduced
by each clone (asjudged by the number of grains counted per cell) varied among
the FT clones, with clones A2, G12, and F1 producing the highest and clone H5
the lowest amount of IL-4-mRNA (Fig . 5) .
We were confronted with technical drawbacks to assess in biological assays the
production of IL-4 by the FT clones . While supernatants from PMA + ionomy-
cin-stimulated FT clones supported proliferation of cells known to respond to
IL-4 (e.g ., C4-86 [10], HT-2, freshly isolated FT), we could neither rule out the
contribution ofPMA + ionomycin in the responses nor ascertain that the growth-
promoting activity in such responses wasdue to IL-4 (the target cells can respond
to other growth factors, e.g ., IL-2, IL-3) . Also, the presence ofPMA + ionomycin
in the supernatants made it very difficult to test them for IgGI-inducing activity
on LPS-stimulated B cells, as the drugs inhibited such responses .
The capacity of the FT clones to assist B lymphocytes to mature into antibody-
secreting cells was determined on a Con A-facilitated microculture assay that
reveals Th activity for B cells regardless of the specificity of the effector and
target cells (23) . A Th line (LD1) was included in these experiments and served1254
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FIGURE 5.
￿
Synthesis ofmRNA for IL-4 by the FT clones after their stimulation with PMA
+ ionomycin as assessed by RNA-RNA in situ hybridization . The results obtained with cells
from four FT clones and the LDI T cell line (negative control) are shown above ; similar
results were obtained with the other FT clones . Unstimulated cells didnot contain detectable
IL-4-mRNA.
as positive control . The number ofantibody-secreting cells (PFC) was determined
by the proteinA plaque assay after 5 d of culture at 37 °C.We found that while
the LD 1 T cell line assisted B lymphocytes to generate antibody-secreting cells,
none of the eight FT clones at the various concentrations tested exhibited this
function (data not shown) .
All FT clones were tested for cytolytic activity on "Cr-labeled target cells
(LPS-activated syngeneic and allogeneic spleen cells or EL-4 T lymphoma cells)
in a lectin-facilitated microcytotoxicity assay that reveals cytotoxic function
regardless of the specificity of the effector cells . AT killer cell line (4E7) was
included in the experiments as a positive control . None of the FT clones exert
killer activity, whereas the 4E7 T cell line (positive control) efficiently killed the
target cells (data not shown) .
Discussion
We have studied the molecular, cellular, and functional properties of the FT
clones (1311, H5, D5, H12, G12, E10, F1, and A2) isolated from the thymus of
a 14-d-old B10.BR mouse fetus.
The FT clones express mRNA for the -y chain gene, but no evidence for
rearrangements of any of the 7 genes was found. The expression of germline
transcripts for the 'Y gene in the FT clones could reflect the accessibility of the
chromatin to recombinases as proposed for the germline transcripts for the Ig
heavy chain gene found in earlyB cell precursor lines (34) . The finding that 1 d
later in ontogeny (day 15 of gestation), FT with rearranged 'r gene clusters are
often found (11-13 ; Pelkonen, J., unpublished results) is consistent with this
view .
The FT clones have neither rearranged the TCR-,Q gene nor do they expressPELKONEN ET AL.
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detectable mRNA for either the TCR-a or -,8 genes, indicating that they are at
a very early stage of development. The rearrangement of the ,Q genes is often
detected at day 15 of gestation (11, 13, 15).
The FT clones express the L3T4 and/or the Lyt-2 T cell differentiation
antigens. It probably reflects the effect ofIL-4 on the FT clones as we previously
found (19) with heterogeneous populations of FT that rIL-4 induces some of
these cells to express Lyt-2. The failure to detect L3T4+ cells in such studies
could be due to the sensitivity of the FAGS analysis coupled to the lower
frequency ofcells induced to express L3T4 by IL-4 (2 of 10 FT clones analyzed)
andto the constant exposure ofthecellsto PMA. PMA may inhibit theexpression
of L3T4 by FT cultured in vitro (Palacios, R., unpublished observations). The
data obtained here with the FT clones show that the expression of the L3T4
and Lyt-2 surface molecules can precede that ofthe TCR-a, -,B/T3 complex on
the cell membrane. Experiments to be reported elsewhere (Palacios, R., and J.
Pelkonen, manuscript in preparation) showed thatthe FTclones with phenotypes
I and II (Lyt-2+, L3T4") can give rise to Lyt-2+, L3T4+ thymocytes carrying
a,#/T3 T cell antigen receptor on the cell membrane. Thus, during ontogeny,
the expression ofthe Lyt-2 molecule appears to precede that ofthe L3T4 surface
antigen. This view is consistent with the finding that in vivo Lyt-2+, L3T4- FT
are found before Lyt-2+, L3T4+, or Lyt-2-, L3T4+ thymocytes can be observed
(35, 36).
The FT clones grow in rIL-4, which acts on these cells via an IL-2-independent
pathway. Six FT clones also proliferate in rIL-2, albeit to a lesser extent than in
rIL-4. Interestingly, the FT clones A2 and G12 do not have receptors for IL-2
but PMA induces both clones to express functional receptors for IL-2. Thus, the
FT clones A2 and G12 resemble a subpopulation of freshly isolated FT (~30-
50%) that can be induced with PMA to express IL-2-R (37, and Palacios, R.,
unpublished observations). The finding that the FT clones respond to both IL-
2 and IL-4 suggests that single FT can use both interleukins as growth factor.
While the FT clones have not yet reached the stage to exhibit either helper
function for Blymphocytesorcytolytic activity, theyarealreadyable to synthesize
mRNA for IL-4 after stimulation in vitro. The latter functional property resem-
blesthat offreshly isolated 14-d fetal thymocytes (20) andstrengthensthe possible
role ofIL-4 in the process of T cell development within the thymus.
The FT clones should prove valuable to address the questions as to what
determines that a given precursor gives rise to T cells that recognize antigen in
the context ofeither class I or class II MHC products, whether a single precursor
can generate both T cells having TCR made of a,f/T3 complex and T cells
carrying TCR y/T3 complexes on the cell membrane, andtostudythe regulation
ofthe expression ofthe TCR-y, -#, and -a genes.
Summary
We have established in culture 13 clones from the thymus ofa 14-d B10.BR
mouse embryo and characterized 8 ofthem. All eight FT clones have the TCR-
y and -,8 genes in germline configuration. They express mRNA for the y, but
not for the Q nor the a genes. All eight FT clones are Thy-1+, Ly-1+, LFA-1+,
Pgp-1+, H-2K+, and T3-. Three phenotypes could be distinguished on the basis1256
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of Lyt-2, L3T4, and IL-2-R expression: Lyt-2+, L3T4-, IL-2-R' (1); Lyt-2',
L3T4-, IL-2-R- (II); and Lyt-2', L3T4+, IL-2-R+ (III) cells. All eight clones
grow in rIL-4 and six clones also proliferate in rIL-2. Antibodies specific for IL-
2-R inhibit their response to rIL-2 but not to rIL-4. The eight FT clones
synthesize mRNA for IL-4 after stimulation in vitro and none of them exhibit
cytolytic activity or helper function for B lymphocytes. We conclude that the FT
clones are at a very early stage ofTcell development, that the expression ofLyt-
2 and L3T4 surface molecules can precede that of the antigen receptor, and
that the same fetal thymocyte can use both IL-4 and IL-2 as growth factor.
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